JP2018512844A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018512844A5 JP2018512844A5 JP2017549280A JP2017549280A JP2018512844A5 JP 2018512844 A5 JP2018512844 A5 JP 2018512844A5 JP 2017549280 A JP2017549280 A JP 2017549280A JP 2017549280 A JP2017549280 A JP 2017549280A JP 2018512844 A5 JP2018512844 A5 JP 2018512844A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- seq
- nucleic acid
- acid molecule
- acne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012634 fragment Substances 0.000 claims 9
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 150000007523 nucleic acids Chemical class 0.000 claims 7
- 208000002874 Acne Vulgaris Diseases 0.000 claims 6
- 206010000496 acne Diseases 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 208000027866 inflammatory disease Diseases 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 102000008946 Fibrinogen Human genes 0.000 claims 3
- 108010049003 Fibrinogen Proteins 0.000 claims 3
- 201000004681 Psoriasis Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940012952 fibrinogen Drugs 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000010065 bacterial adhesion Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15305414 | 2015-03-20 | ||
| EP15305414.3 | 2015-03-20 | ||
| PCT/EP2016/056179 WO2016150926A1 (en) | 2015-03-20 | 2016-03-21 | Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018512844A JP2018512844A (ja) | 2018-05-24 |
| JP2018512844A5 true JP2018512844A5 (enExample) | 2019-04-25 |
| JP6840086B2 JP6840086B2 (ja) | 2021-03-10 |
Family
ID=52807757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017549280A Active JP6840086B2 (ja) | 2015-03-20 | 2016-03-21 | 薬物として、特に皮膚炎症性疾患において使用するためのフィブリノゲン由来の単離されたペプチドおよびそれらのフラグメント |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10323078B2 (enExample) |
| EP (1) | EP3270950B1 (enExample) |
| JP (1) | JP6840086B2 (enExample) |
| CN (1) | CN107636011B (enExample) |
| AU (1) | AU2016236297B2 (enExample) |
| BR (1) | BR112017020008A8 (enExample) |
| CA (1) | CA2979812C (enExample) |
| DK (1) | DK3270950T3 (enExample) |
| ES (1) | ES2880795T3 (enExample) |
| WO (1) | WO2016150926A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12502424B2 (en) | 2023-05-05 | 2025-12-23 | Sanofi Pasteur Inc. | Compositions for use in treatment of acne |
| CN117304303B (zh) * | 2023-07-14 | 2024-07-05 | 杭州恩和生物科技有限公司 | 纤连蛋白截短片段、组合物及用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2032527C (en) * | 1989-04-10 | 2002-07-02 | Jesse M. Jaynes | Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth |
| US5639940A (en) * | 1994-03-03 | 1997-06-17 | Pharmaceutical Proteins Ltd. | Production of fibrinogen in transgenic animals |
| US6783961B1 (en) * | 1999-02-26 | 2004-08-31 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| CA2296792A1 (en) | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| WO2001001150A2 (en) * | 1999-06-30 | 2001-01-04 | Regents Of The University Of California | Diagnostic test for thrombotic or thromboembolic disease |
| CA2453202C (en) * | 2001-07-06 | 2012-10-16 | Oregon Health & Science University | Peptides which modulate blood coagulation and methods of use thereof |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| AU2004232487A1 (en) * | 2003-04-23 | 2004-11-04 | Hansa Medical Ab | Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections |
| US7807409B2 (en) * | 2005-10-21 | 2010-10-05 | Roche Palo Alto Llc | Method for the recombinant expression of a polypeptide |
| US20130280820A1 (en) * | 2005-12-16 | 2013-10-24 | Schering Corporation | Biomarkers for psoriasis |
| NZ574653A (en) * | 2006-08-04 | 2012-11-30 | Stb Lifesaving Technologies Inc | Solid dressing for treating wounded tissue |
| WO2008116468A2 (en) * | 2007-03-26 | 2008-10-02 | Dako Denmark A/S | Mhc peptide complexes and uses thereof in infectious diseases |
| CN101618211A (zh) * | 2008-07-03 | 2010-01-06 | 珠海联邦制药股份有限公司 | 一种乙肝多肽疫苗及其应用 |
| US20110177524A1 (en) * | 2008-07-09 | 2011-07-21 | Profibrix Bv | Recombinant Fibrinogen |
| US20120052066A1 (en) * | 2008-11-07 | 2012-03-01 | Cesar Calderon | Markers and methods for assessing and treating lupus patients susceptible to photoprovocation |
| EP4012714A1 (en) * | 2010-03-23 | 2022-06-15 | Iogenetics, LLC. | Bioinformatic processes for determination of peptide binding |
| CA2825765C (en) * | 2011-02-02 | 2020-03-10 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Anti-carbamylated protein antibodies and the risk for arthritis |
-
2016
- 2016-03-21 DK DK16713796.7T patent/DK3270950T3/da active
- 2016-03-21 EP EP16713796.7A patent/EP3270950B1/en active Active
- 2016-03-21 BR BR112017020008A patent/BR112017020008A8/pt not_active IP Right Cessation
- 2016-03-21 CA CA2979812A patent/CA2979812C/en active Active
- 2016-03-21 JP JP2017549280A patent/JP6840086B2/ja active Active
- 2016-03-21 US US15/559,984 patent/US10323078B2/en active Active
- 2016-03-21 ES ES16713796T patent/ES2880795T3/es active Active
- 2016-03-21 WO PCT/EP2016/056179 patent/WO2016150926A1/en not_active Ceased
- 2016-03-21 AU AU2016236297A patent/AU2016236297B2/en active Active
- 2016-03-21 CN CN201680026130.XA patent/CN107636011B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201973T1 (hr) | Ligandi modificirani kružnom permutacijom kao agonisti i antagonisti | |
| JP6981878B2 (ja) | 抗菌療法 | |
| WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
| WO2011036445A3 (en) | Polypeptides and uses thereof | |
| JP2015510393A5 (enExample) | ||
| JP2018506286A5 (enExample) | ||
| JP2016526885A5 (enExample) | ||
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| JP2017532343A5 (enExample) | ||
| JP2017529326A5 (enExample) | ||
| WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| JPWO2019156137A5 (enExample) | ||
| JP2018538356A5 (enExample) | ||
| CL2019003408A1 (es) | Péptido asociados a tumor (tumap) aislado; ácido nucleico; vector de expresión; célula huésped recombinante que comprendes el péptido; método para producir el péptido; uso para preparar un medicamento útil rara tratar el cáncer; kit farmacéutico. (divisional solicitud 201702407) | |
| CN110799522A (zh) | 用于治疗、改善或预防脑出血的肽及其用途 | |
| JP2015522264A5 (enExample) | ||
| JP2018537089A5 (enExample) | ||
| ATE500265T1 (de) | Synthetische mecp2-sequenz für die proteinersatztherapie | |
| JP2017039729A5 (enExample) | ||
| IL269187B2 (en) | Dominant active yap, a hippo effector, induces chromatin accessiblity and cardiomyocyte renewal | |
| RU2017124487A (ru) | НОВЫЙ ПЕПТИД-ИНГИБИТОР PI3Kγ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ОРГАНОВ ДЫХАНИЯ | |
| JP2019505567A5 (enExample) | ||
| JP2017519763A5 (enExample) | ||
| JP2018512844A5 (enExample) |